Two former Insys saleswomen have copped to charges that they took part in a kickback scheme designed to push sales of pain drug Subsys.

Israel’s Teva is suing a former U.S. employee over allegations she shared company secrets with her boyfriend, the CEO of rival Apotex.

Gilead hit with revived lawsuit claiming it sourced a key HIV drug ingredient from an unapproved Chinese manufacturer.

Boehringer Ingelheim has scored a key victory in a patent battle with AbbVie over Humira, the world's top-selling drug.

The generic drug industry is pushing back hard against a new pricing law in Maryland.

Under pressure from the FDA, Endo will voluntarily pull its opioid painkiller Opana ER from the market.

Allergan agreed to hand over $13 million to settle kickback allegations with the U.S. and 19 states.

Former AstraZeneca exec Luke Miels starts soon at crosstown rival GSK, but court papers illustrate how personal defections like this can get.

In a new countersuit against Express Scripts, Kaleo says it's owed at least $5.3 million.